1.Chinese Medical Association-L′Oréal China Skin & Hair Research Grant result summary—skin
Michèle VERSCHOORE ; Yueqing NIU ; Stéphane COMMO ; Léopold MULLER ; Yuhao WEI ; Yaxian ZHEN ; Wei LIU
Chinese Journal of Dermatology 2024;57(5):464-467
Chinese Medical Association and L'Oréal Group jointly launched the "China Skin & Hair Grant" from 2003 to 2018 to support Chinese dermatologists in skin and hair research. This program has not only helped improve the research capability of Chinese dermatologists, but also yielded abundant valuable Chinese population-based clinical and basic research results, and further enabled active academic communication through Chinese and international journals and conferences. This article summarizes main results from skin-related research projects based on program records and publications.
2.What’s new in breast pathology 2022: WHO 5th edition and biomarker updates
Kristen MULLER ; Julie M. JORNS ; Gary TOZBIKIAN
Journal of Pathology and Translational Medicine 2022;56(3):170-171
The 5th edition WHO Classification of Breast Tumours (2019) has introduced changes to our practices. Highlights are presented below, with a focus on modifications to morphological subtype categorization. In addition, we summarize important updates to ER and PR testing made in the 2020 ASCO/CAP guidelines, and briefly discuss PD-L1 and Ki-67 testing in breast cancer.
3.Clinical and laboratory profile in confirmed vs. suspected septic arthritis patients and its relevance in decision making: A comparative cross-sectional study.
Sandeep K NEMA ; Suman Kumar BASEL ; Jose AUSTINE ; Kiyana MIRZA
Chinese Journal of Traumatology 2021;24(2):94-99
PURPOSE:
There were 10%-30% of patients with adult-onset septic arthritis (SA) exhibiting sterile synovial fluid (SF), and the uncertainty in the determining diagnosis of these patients posed a challenge in management. The purpose of this study was to investigate the differences between confirmed (Newman A) and suspected (Newman B & C) SA in adults.
METHODS:
This was a descriptive study with a cross-sectional study design conducted at a tertiary referral centre from July 2016 to February 2019. Patients aged over 18 years presented to the emergency department with clinical features suggestive of SA and were scheduled to undergo arthrotomy and joint lavage by the treating surgeon were included in the study. Patients with prosthetic joint infections and open joint injuries were excluded. Patients' demographic data, clinical features and laboratory parameters were collected. The clinical and laboratory profile (blood and SF) of the adult patients presenting with features suggestive of SA based on Newman criteria was statistically analyzed by SPSS version 20 software and Microsoft Excel. The categorical variables were expressed as proportions while the continuous variables were expressed as mean (SD) or median (IQR) depending upon the normality of distribution. The difference between the two groups for categorical variables was assessed using the Chi-square test and the difference for continuous variables was assessed using the unpaired t-test and the Mann-Whitney test depending upon normality. A p value < 0.05 was considered significant.
RESULTS:
Thirty-six patients were divided into confirmed (n = 19) or suspected (n = 17) SA for assessment based on SF culture. The median (IQR) age of the patients was 50 years (37-60 years). There was no significant difference in demographic, clinical and laboratory parameters between the concerned groups. Eight patients presented with fever. Among the confirmed SA cases, 8 were negative for C-reactive protein and 6 had synovial white blood cell count <50,000. Staphylococcus species were isolated in 8 cases. The most common risk factors for SA were chronic kidney disease (25.0%), diabetes mellitus (25.0%), pharmacologic immunosuppression (16.7%), recent joint surgery (11.1%) and distant site infection (11.1%).
CONCLUSION
SA is an orthopaedic emergency that needs prompt and aggressive treatment to prevent catastrophic complications. Confirmed and suspected cases of SA exhibit similar demography, clinical features and laboratory parameters at presentation which may mislead the treating surgeon. Management should be based on sound clinical judgment in the event of failure to culture microorganisms.
4.Transient cortical blindness in fat embolism syndrome---a diagnostic enigma.
Kiyana MIRZA ; Prashant Upendra ACHARYA ; Jose AUSTINE
Chinese Journal of Traumatology 2021;24(2):79-82
Fat embolism syndrome (FES) is a serious life-threatening manifestation of the fat embolism phenomenon characterized by Bergman's triad of dyspnea, petechiae and mental confusion. While fat embolization into systemic circulation is common, FES occurs in a meagre 0.05%-3% of patients having isolated long bone fractures. Though visual symptoms are commonly attributed to fat embolism retinopathy and is a later occurrence, it may not always be the case. Cortical blindness has been seldom reported in association with FES, and less so as a presenting complaint. Furthermore, no previous literature has described the same in context of an isolated tibia fracture. We report a 20-year-old gentleman with an isolated right tibia shaft fracture who developed sudden onset diminution of vision in both eyes less than 24 h following trauma with no other complaints. Lack of any remarkable ophthalmoscopic findings or other symptoms left us with a diagnostic conundrum. He later went on to develop altered mentation, hypoxia and generalized tonic-clonic seizures with subsequent MRI revealing multiple cerebral fat emboli also involving both occipital lobes. Supportive measures were instituted and his general condition as well as vision gradually improved following which he underwent plate fixation of the fracture under spinal anaesthesia. The perioperative period was uneventful and he was discharged following staple removal. At one month of follow-up, the patient had no residual visual field defects or neurological deficits. Though FES is rare among isolated tibia fractures, this clinical catastrophe may strike in any unsuspected setting thereby warranting a high index of suspicion to ensure early diagnosis and improved patient outcomes.
6.Is Follow-up of Adrenal Incidentalomas Always Mandatory?
Giuseppe REIMONDO ; Alessandra MULLER ; Elisa INGARGIOLA ; Soraya PUGLISI ; Massimo TERZOLO
Endocrinology and Metabolism 2020;35(1):26-35
Adrenal masses are mainly detected unexpectedly by an imaging study performed for reasons unrelated to any suspect of adrenal diseases. Such masses are commonly defined as “adrenal incidentalomas†and represent a public health challenge because they are increasingly recognized in current medical practice. Management of adrenal incidentalomas is currently matter of debate. Although there is consensus on the need of a multidisciplinary expert team evaluation and surgical approach in patients with significant hormonal excess and/or radiological findings suspicious of malignancy demonstrated at the diagnosis or during follow-up, the inconsistency between official guidelines and the consequent diffuse uncertainty on management of small adrenal incidentalomas still represents a considerable problem in terms of clinical choices in real practice. The aim of the present work is to review the proposed strategies on how to manage patients with adrenal incidentalomas that are not candidates to immediate surgery. The recent European Society of Endocrinology/European Network for the Study of Adrenal Tumors guidelines have supported the view to avoid surveillance in patients with clear benign adrenal lesions <4 cm and/or without any hormonal secretion; however, newer prospective studies are needed to confirm safety of this strategy, in particular in younger patients.
7.Additive manufacturing to veterinary practice: recovery of bony defects after the osteosarcoma resection in canines
Vladimir V POPOV ; Gary MULLER-KAMSKII ; Alexander KATZ-DEMYANETZ ; Aleksey KOVALEVSKY ; Stas USOV ; Dmitrii TROFIMCOW ; Georgy DZHENZHERA ; Andrey KOPTYUG
Biomedical Engineering Letters 2019;9(1):97-108
The paper outlines the achievements and challenges in the additive manufacturing (AM) application to veterinary practice. The state-of-the-art in AM application to the veterinary surgery is presented, with the focus of AM for patient-specifi c implants manufacturing. It also provides critical discussion on some of the potential issues design and technology should overcome for wider and more eff ective implementation of additively manufactured parts in veterinary practices. Most of the discussions in present paper are related to the metallic implants, manufactured in this case using so-called powder bed additive manufacturing (PB-AM) in titanium alloy Ti–6AL–4V, and to the corresponding process of their design, manufacturing and implementation in veterinary surgery. Procedures of the implant design and individualization for veterinary surgery are illustrated basing on the four performed surgery cases with dog patients. Results of the replacement surgery in dogs indicate that individualized additively manufactured metallic implants signifi cantly increase chances for successful recovery process, and AM techniques present a viable alternative to amputation in a large number of veterinary cases. The same time overcoming challenges of implant individualization in veterinary practice signifi cantly contributes to the knowledge directly relevant to the modern medical practice. An experience from veterinary cases where organ-preserving surgery with 3D-printed patient-specifi c implants is performed provides a unique opportunity for future development of better human implants.
Alloys
;
Amputation
;
Animals
;
Dogs
;
Humans
;
Osteosarcoma
;
Surgery, Veterinary
;
Titanium
8.Design and 3D-printing of titanium bone implants: brief review of approach and clinical cases.
Vladimir V POPOV ; Gary MULLER-KAMSKII ; Aleksey KOVALEVSKY ; Georgy DZHENZHERA ; Evgeny STROKIN ; Anastasia KOLOMIETS ; Jean RAMON
Biomedical Engineering Letters 2018;8(4):337-344
Additive manufacturing (AM) is an alternative metal fabrication technology. The outstanding advantage of AM (3D-printing, direct manufacturing), is the ability to form shapes that cannot be formed with any other traditional technology. 3D-printing began as a new method of prototyping in plastics. Nowadays, AM in metals allows to realize not only net-shape geometry, but also high fatigue strength and corrosion resistant parts. This success of AM in metals enables new applications of the technology in important fields, such as production of medical implants. The 3D-printing of medical implants is an extremely rapidly developing application. The success of this development lies in the fact that patient-specific implants can promote patient recovery, as often it is the only alternative to amputation. The production of AM implants provides a relatively fast and effective solution for complex surgical cases. However, there are still numerous challenging open issues in medical 3D-printing. The goal of the current research review is to explain the whole technological and design chain of bio-medical bone implant production from the computed tomography that is performed by the surgeon, to conversion to a computer aided drawing file, to production of implants, including the necessary post-processing procedures and certification. The current work presents examples that were produced by joint work of Polygon Medical Engineering, Russia and by TechMed, the AM Center of Israel Institute of Metals. Polygon provided 3D-planning and 3D-modelling specifically for the implants production. TechMed were in charge of the optimization of models and they manufactured the implants by Electron-Beam Melting (EBM®), using an Arcam EBM® A2X machine.
Amputation
;
Certification
;
Corrosion
;
Fatigue
;
Freezing
;
Humans
;
Israel
;
Joints
;
Metals
;
Methods
;
Plastics
;
Russia
;
Titanium*
9.¹⁸F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation
Nastassja MULLER ; Romain KESSLER ; Sophie CAILLARD ; Eric EPAILLY ; Fabrice HUBELÉ ; Céline HEIMBURGER ; Izzie Jacques NAMER ; Raoul HERBRECHT ; Cyrille BLONDET ; Alessio IMPERIALE
Nuclear Medicine and Molecular Imaging 2017;51(1):58-68
PURPOSE: Infection and malignancy represent two common complications after solid organ transplantation, which are often characterized by poorly specific clinical symptomatology. Herein, we have evaluated the role of 18F-fluoro-2-deoxy-Dglucose (FDG) positron emission tomography/computed tomography (PET/CT) in this clinical setting.METHODS: Fifty-eight consecutive patients who underwent FDG PET/CT after kidney, lung or heart transplantation were included in this retrospective analysis. Twelve patients underwent FDGPET/CT to strengthen or confirma diagnostic suspicion of malignancies. The remaining 46 patients presented with unexplained inflammatory syndrome, fever of unknown origin (FUO), CMVor EBV seroconversion during post-transplant follow-up without conclusive conventional imaging. FDG PET/CT results were compared to histology or to the finding obtained during a clinical/imaging follow-up period of at least 6 months after PET/CT study.RESULTS: Positive FDG PET/CT results were obtained in 18 (31 %) patients. In the remaining 40 (69 %) cases, FDG PET/CT was negative, showing exclusively a physiological radiotracer distribution. On the basis of a patient-based analysis, FDG PET/CT's sensitivity, specificity, PPV and NPV were respectively 78 %, 90 %, 78 % and 90 %, with a global accuracy of 86 %. FDG PET/CT was true positive in 14 patients with bacterial pneumonias (n = 4), pulmonary fungal infection (n = 1), histoplasmosis (n = 1), cutaneous abscess (n = 1), inflammatory disorder (sacroiliitis) (n = 1), lymphoma (n = 3) and NSCLC (n = 3). On the other hand, FDG PET/CT failed to detect lung bronchoalveolar adenocarcinoma, septicemia, endocarditis and graft-versus-host disease (GVHD), respectively, in four patients. FDG PET/CT contributed to adjusting the patient therapeutic strategy in 40 % of cases.CONCLUSIONS: FDG PET/CT emerges as a valuable technique to manage complications in the post-transplantation period. FDG PET/CT should be considered in patients with severe unexplained inflammatory syndrome or FUO and inconclusive conventional imaging or to discriminate active from silent lesions previously detected by conventional imaging particularly when malignancy is suspected.
Abscess
;
Adenocarcinoma
;
Diagnosis
;
Electrons
;
Endocarditis
;
Fever of Unknown Origin
;
Follow-Up Studies
;
Graft vs Host Disease
;
Hand
;
Heart Transplantation
;
Herpesvirus 4, Human
;
Histoplasmosis
;
Humans
;
Kidney
;
Lung
;
Lung Diseases, Fungal
;
Lymphoma
;
Organ Transplantation
;
Pneumonia, Bacterial
;
Positron-Emission Tomography and Computed Tomography
;
Retrospective Studies
;
Sensitivity and Specificity
;
Sepsis
;
Seroconversion
;
Transplants
10.Ability of endophytic fungi isolated from Nepenthes ampullaria to degrade polyurethane
Shirley Bong Wuan Lii ; Changi Wong ; Muller
Malaysian Journal of Microbiology 2017;13(3):172-179
Aims: Waste electric and electronic equipment (WEEE) are among the fastest growing waste products worldwide and
solutions to their remediation are urgently needed. Bioremediation is a green approach that is helpful to minimize
environmental pollution associated with Electronic waste (E-waste). The present study aimed at exploring the potential
of endophytic fungi from Nepenthes ampullaria for bioremediation purposes of the plastic component in E-waste,
polyurethane (PUR) polymers.
Methodology and results: Endophytic fungal isolates were assessed for their ability to degrade PUR as well as their
ability to utilise PUR as sole carbon source. Nine (9) out of 150 isolates demonstrated the ability to efficiently degrade
polyurethane in solid medium and the top three (3) isolates were able to grow on PUR as the only carbon source. These
three isolates were identified using ITS1 and ITS4 and found to be closely related to the genus Pestalotiopsis. The top
two of the three isolates were then assessed for their esterase enzyme activity as well as changes in their proteome
when grown with and without PUR. The highest enzymatic activity was found to be 1850.4 U/mL when tested using pnitrophenol
acetate as the substrate. Analyses of the 2-dimensional electrophoresis profile revealed changes in the
abundance of proteins when treated with polyurethane.
Conclusion, significance and impact of study: This study is to our knowledge the first on endophytes isolated from N.
ampullaria that can degrade PUR, and also their proteomes. Results obtained from this study can in the future help to
reduce polyurethane wastes. Besides degrading PUR polymer, endophytic fungi produce potential valuable proteins that
may find broad applications in bioremediation applications.

Result Analysis
Print
Save
E-mail